As of the latest Form 4 filed Jul 2, 2026.
What Bausch Health Companies Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 35 most recent filings for BHC.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-06-30 | WECHSLER AMY B Director | AAward | +1.39K | $4.93 | $6.87K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Paulson John Director | AAward | +12.7K | $4.93 | $62.5K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | LEUNG SANDRA Director | AAward | +6.84K | $4.93 | $33.7K | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | WECHSLER AMY B Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | ROBERTS EIRY Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | POWER ROBERT N Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | Paulson John Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | LEUNG SANDRA Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | Lee Frank D. Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | KAVANAGH SARAH B Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | GOETTLER MICHAEL Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | Garcia Christian A Director | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Lee Frank D. Director | SSale | −24.5K | $5.43 | $133K | Yes (planned) | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | LEUNG SANDRA Director | AAward | +5.95K | $5.40 | $32.1K | No | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | Paulson John Director | AAward | +11.6K | $5.40 | $62.5K | No | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | WECHSLER AMY B Director | AAward | +1.27K | $5.40 | $6.87K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-03 | Carson Seana EVP, General Counsel | SSale | −4.42K | $5.77 | $25.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Carson Seana, EVP, General Counsel | JOther | −138K | $5.95 | $821K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Carson Seana, EVP, General Counsel | FTax | −17.0K | $5.95 | $101K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Carson Seana, EVP, General Counsel | SSale | −6.86K | $5.78 | $39.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | APPIO THOMAS Chief Executive Officer | JOther | −1.14M | $5.95 | $6.77M | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | APPIO THOMAS, Chief Executive Officer | FTax | −83.7K | $5.95 | $498K | No | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Charhon Jean-Jacques EVP, CFO | FTax | −49.1K | $5.93 | $291K | No | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Carson Seana EVP, General Counsel | FTax | −26.3K | $5.93 | $156K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | APPIO THOMAS Chief Executive Officer | FTax | −83.1K | $5.93 | $493K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-27 | Carson Seana EVP, General Counsel | SSale | −8.39K | $5.95 | $49.9K | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Lenar Aimee J. EVP, US Pharma | FTax | −17.6K | $6.04 | $106K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Carson Seana EVP, General Counsel | FTax | −32.2K | $6.04 | $195K | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Charhon Jean-Jacques EVP, CFO | FTax | −36.0K | $6.04 | $217K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | APPIO THOMAS Chief Executive Officer | FTax | −117K | $6.04 | $704K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | LEE STEVEN HYOSIG SVP, Controller & CAO | AAward | +45.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Lenar Aimee J. EVP, US Pharma | AAward | +157K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Carson Seana EVP, General Counsel | AAward | +212K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Charhon Jean-Jacques EVP, CFO | AAward | +276K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | APPIO THOMAS Chief Executive Officer | AAward | +815K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also BHC’s full analysis or the market-wide insider trading feed. The tabs above jump to BHC’s other SEC data.
Source: SEC Form 4 filings for BHC, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.